Previous studies reported human immunodeficiency virus (HIV) could enhance human
papillomavirus (HPV)‐induced cervical cancer. Therefore, the burden of cervical cancer …

Background HIV enhances human papillomavirus (HPV)-induced carcinogenesis. However,
the contribution of HIV to cervical cancer burden at a population level has not been …

HIV substantially worsens human papillomavirus (HPV) carcinogenicity and contributes to
an important population excess of cervical cancer, particularly in sub‐Saharan Africa (SSA) …

Methods: A retrospective study using the PEPFAR Panorama CC data, from 13 countries
from SSA, was performed. We calculated the proportions of women who were screened …

Introduction Women living with HIV experience heightened risk of cervical cancer, and over
50% of cases in Southern Africa are attributed to HIV co-infection. Cervical cancer …

In the preantiretroviral therapy (ART) era, a 1987 UK case series suggested that young
women living with HIV could have shockingly rapid progression of cervical dysplasia to …

Background Cervical cancer is one of the most common cancers among women worldwide.
The formulation or evaluation on prevention strategies all require an accurate understanding …

We compared invasive cervical cancer (ICC) incidence rates in Europe, South Africa, Latin
and North America among women living with HIV who initiated antiretroviral therapy (ART) …

Objective: Recommendations for the age of initiating screening for cervical cancer in women
with HIV (WWH) in the United States have not changed since 1995 when all women …

Background Although cervical cancer risk overall is elevated among women living with
human immunodeficiency virus (HIV; WLH), it is unclear whether risks are similarly elevated …